Home > Income Statement > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
Revenue

    Back to Income Statement
SOTAC PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SOTAC PHARMACEUTICALS
Please provide your vote to see the results

SOTAC PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹101 Cr₹100 Cr₹104 Cr₹77 Cr₹73 Cr

What is the latest Revenue of SOTAC PHARMACEUTICALS ?

The latest Revenue ratio of SOTAC PHARMACEUTICALS is ₹101 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹101 Cr
Mar2025₹100 Cr
Mar2024₹104 Cr
Mar2023₹77 Cr
Mar2022₹73 Cr

How is Revenue of SOTAC PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2026 ₹101 Cr
1.51
Mar2025 ₹100 Cr
-3.94
Mar2024 ₹104 Cr
34.00
Mar2023 ₹77 Cr
5.92
Mar2022 ₹73 Cr -

Compare Revenue of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹142.3 Cr 5.3% 23.2% -27.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹452,707.0 Cr 1.4% 6.7% 12% Stock Analytics
DIVIS LABORATORIES ₹303,962.0 Cr 11.1% 23.5% 70% Stock Analytics
TORRENT PHARMACEUTICALS ₹179,494.0 Cr 1% 1.8% 34.3% Stock Analytics
DR REDDYS LABORATORIES ₹115,769.0 Cr 1.1% 11.8% 14.2% Stock Analytics
CIPLA ₹113,912.0 Cr 0.1% 6% -5.8% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

5.3%

23.2%

-27.8%

SENSEX

3.3%

13.9%

-1.7%


You may also like the below Video Courses